Showing results (41-50 of 496) with videos related to
Sort By:
Pageof 50
The Prostate|November 7, 2017
Circulating microRNAs and treatment response in the Phase II SWOG S0925 study for patients with new metastatic hormone-sensitive prostate cancerHeather H Cheng, Melissa Plets, Hongli Li, et al.Prostate Cancer and Prostatic Diseases|February 15, 2020
Survival outcomes and risk group validation from SWOG S0925: a randomized phase II study of cixutumumab in new metastatic hormone-sensitive prostate cancerRisa L Wong, Mai T Duong, Catherine M Tangen, et al.Seminars in Oncology|October 5, 2015
Ongoing Use of Data and Specimens From National Cancer Institute-Sponsored Cancer Prevention Clinical Trials in the Community Clinical Oncology ProgramLori M Minasian, Catherine M Tangen, D Lawrence WickerhamThe Journal of Urology|January 27, 2009
Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trialIan M Thompson, Catherine M Tangen, Jorge Paradelo, et al.The Journal of Urology|October 24, 2002
Neoadjuvant therapy before radical prostatectomy for clinical T3/T4 carcinoma of the prostate: 5-year followup, Phase II Southwest Oncology Group Study 9109Isaac J Powell, Catherine M Tangen, Gary J Miller, et al.JAMA|November 16, 2006
Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trialIan M Thompson, Catherine M Tangen, Jorge Paradelo, et al.Journal of the National Cancer Institute|August 28, 2016
Long-term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention TrialJoseph M Unger, Cathee Till, Ian M Thompson, et al.Cancer Prevention Research (Philadelphia, Pa.)|February 28, 2020
Vitamin D Pathway and Other Related Polymorphisms and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention TrialKathleen Torkko, Cathee Till, Catherine M Tangen, et al.JAMA Oncology|November 7, 2024
Long-Term Adverse Effects and Complications After Prostate Cancer TreatmentJoseph M Unger, Cathee Till, Catherine M Tangen, et al.The Journal of Urology|July 24, 2007
Chemoprevention of prostate cancer: agents and study designsIan M ThompsonPageof 50